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ABSTRACT
Brucella microti was isolated a decade ago from wildlife and soil in Europe. Compared to the
classical Brucella species, it exhibits atypical virulence properties such as increased growth in
human and murine macrophages and lethality in experimentally infected mice. A spontaneous
rough (R) mutant strain, derived from the smooth reference strain CCM4915T, showed increased
macrophage colonization and was non-lethal in murine infections. Whole-genome sequencing
and construction of an isogenic mutant of B. microti and Brucella suis 1330 revealed that the
R-phenotype was due to a deletion in a single gene, namely wbkE (BMI_I539), encoding a putative
glycosyltransferase involved in lipopolysaccharide (LPS) O-polysaccharide biosynthesis.
Complementation of the R-strains with the wbkE gene restored the smooth phenotype and the
ability of B. microti to kill infected mice. LPS with an intact O-polysaccharide is therefore essential
for lethal B. microti infections in the murine model, demonstrating its importance in pathogenesis.
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Introduction
Brucellae are Gram-negative facultative intracellular coc-
cobacilli causing brucellosis, a major bacterial zoonosis
with 500,000 human cases globally reported every year
[1]. In the last decade, new species of Brucella, such as
Brucella microti, Brucella inopinata and isolates from
Australian rodents and amphibians, have been described
[2]. These strains are metabolically more active, acid-
resistant and fast-growing when compared to the well-
known classical, human-pathogenic Brucella species,
which include Brucella abortus, Brucella melitensis,
Brucella suis and Brucella canis [2–7]. Their isolation
from hitherto unknown wildlife hosts and the environ-
ment raised the question whether Brucella may be trans-
mitted from these reservoirs to livestock and humans
living in officially brucellosis-free areas of the world.
B. microtiwas isolated from common vole, red fox, wild
boar, and soil in Central Europe and, more recently, from
a domestic marsh frog farm [8,9]. Phylogenetically, this
species is closer to those pathogenic for human and
livestock than to the group of newly described atypical
species/strains [2,10]. However, in the absence of clinical
reports, the pathogenic potential ofB.microti remains to be
verified. We were the first to describe that, unlike the
classical Brucella species, B. microti is lethal in mice when
injected intraperitoneally (i.p.) at a standard dose [11]. The
lethal phenotype in mice depends on the type IV secretion
system VirB [12] and is also a general unambiguous criter-
ion to establish if a specific Brucella gene plays a role in
virulence of B. microti, as wild-type bacteria kill the murine
host at the infection dose of 105 CFU (colony-forming
units); in contrast, in classical species virulence has been
correlated to the capacity of a strain to establish or main-
tain various degrees of chronic infection of the spleen and/
or the liver, necessitating repeated bacterial enumeration in
these organs to follow up the course of infection. On the
other hand, at sub-lethal doses (≤104 CFU), B. microti is
rapidly cleared from infected mice, never gives rise to
chronic infection and confers protection [11]. Lethality in
mice was later also demonstrated for B. inopinata BO1 and
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Brucella strain 83–210 [13]. We and others assumed that
the ability of these Brucella species to kill the murine host
may be due to differences in surface antigens, in particular
the structure of lipopolysaccharide (LPS) with a possibly
higher endotoxic potential [13,14]. Because of its low endo-
toxicity, the LPS of classical Brucella species is considered
as non-canonical in comparison with that of Escherichia
coli and other pathogenic bacteria, enabling Brucella to
establish chronic infections and evade TLR4 detection
[15–17]. The LPS is a major component of the outer
membrane and consists of three key elements: (1) the
lipid A, which provides the hydrophobic LPS anchor in
the outermembrane, (2) an inner and outer core composed
of branched-chain oligosaccharides, and (3) an
O-polysaccharide (O-PS), linked to the outer core and
protruding into the extracellular environment. In
Brucella, the O-PS is characterized by a homopolymeric
linear chain of N-formyl-perosamine residues linked via α-
1,2 and/or α-1,3 glycosidic bonds [18]. Depending on the
relative abundance and distribution of these bonds, the
O-PS provides the A, M, and common (C) epitopes widely
used for serotyping [19,20]. Depending on the presence or
absence of theO-PS, the colony phenotype is either smooth
(S) or rough (R). All Brucella species that infect humans
and livestock are naturally S, except for Brucella ovis and
B. canis [21]. For vaccination of livestock against brucello-
sis, S- and R-strains have been used [22].
Notably, a specific interaction between intact LPS
and the lipid rafts in phagocytic cells is responsible
for the selective entry of Brucella S-strains into the
host cells and trafficking along the endocytic pathway
[23–26]. In contrast, R strains do not enter the cell
through the lipid rafts and are rapidly eliminated [25].
In this study, we characterized a spontaneous
R-mutant (BmRSM) of the B. microti reference strain
CCM4915T. Its complete genome sequence helped to
identify a mutation inactivating the wbkE gene, known
to be involved in the synthesis of O-PS [27]. To corre-
late this mutation with the R phenotype and virulence,
we constructed a knock-out mutant (BmRΔwbkE) by
allelic exchange. The fate of RSM, RΔwbkE and their
complemented strains in cellular and murine infection
models was studied and compared to that of the zoo-
notic strain B. suis 1330.
Material and methods
Bacterial strains, culture conditions and phenotypic
characterization
E. coli and Brucella strains (Table 1) were grown under
aerobic conditions at 37°C in Luria Bertani (LB,
Invitrogen) and Tryptic Soy (TS, Difco) media, respectively.
When necessary, media were supplemented with kanamy-
cin or ampicillin at 50 µg/ml, or with chloramphenicol at
25 µg/ml. All experiments with viable Brucella were per-
formed in a BSL-3 facility. The smooth (S) and rough (R)
phenotypes of Brucella were assessed by crystal violet stain-
ing [28] and by agglutination tests using anti-R polyclonal
antiserum and anti-A and anti-M monospecific sera
(ANSES, France). Bacterial morphology was observed by
atomic force microscopy (AFM).
DNA analysis and mutant strains construction
Genomic DNA of B. microti was isolated using the
Qiagen Mini Kit. Whole-genome shotgun sequencing
of the spontaneous rough strain (BmRSM) was per-
formed using Illumina paired-end sequencing with
a library insert size of 300 bp and an average target
coverage of 484 x (GATC). BmRΔwbkE of B. microti was
obtained by replacing an internal portion of gene
BMI_I539 with a KanR cassette. A recombinant wbkE-
KanR-containing plasmid derived from pGEM®-T was
created as previously described [5,30]. Briefly, two
DNA fragments (A, 526 bp and B, 595 bp) each carry-
ing an EcoRI restriction site in a 46-bp homology
region at the 3ʹ- and 5ʹ-end, respectively, were ampli-
fied by PCR. The fragments were fused in a second
PCR, to yield fragment AB (1075 bp) containing the
EcoRI site in the middle and missing 608 out of 1110 bp
of the target gene BMI_I539 (i.e. from positions 71 to
678; Table 1). Following cloning of fragment AB in
pGEM-T, the resulting plasmid (pGEM-T-AB;
Table 1) was digested with EcoRI and ligated with the
KanR cassette (1282 bp) excised from plasmid pUC4K.
The resulting plasmid (pGEM-T-ABKan, 5357 bp;
Table 1) was electroporated into B. microti. The
KanR/AmpS clones arising from double-crossover were
selected and verified by PCR (primers in Table 1). Same
constructions and protocols were used to obtain the
ΔwbkE mutant of B. suis (BsRΔwbkE; Table 1).
Using electroporation, the three mutant strains
(BmRSM, BmRΔwbkE, BsRΔwbkE) were complemented
with pBBR1MCS-wbkE vector, containing the wild-
type B. microti wbkE gene and its up- and downstream
regions (Table 1).
Atomic force microscopy
Bacteria were grown to stationary phase in TS, washed
in PBS, fixed for 1 h in 2.5% glutaraldehyde and stored
in PBS at 5 × 109 bacteria/ml. FluoroDish™ cell culture
dishes (World Precision Instruments, UK) were coated
overnight at 4°C with 0.1% poly-L-lysine, washed with
PBS, air dried and stored at 4°C. Bacteria were diluted
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20-fold in PBS and added to the functionalized dish.
Images were recorded with qp-BioAC CB2 cantilevers
using the quantitative imaging mode available on the
NanoWizard IV AFM (JPK Instruments – Bruker). The
applied force was kept at 0.3 nN, and a constant
approach/retract speed of 80 µm/s (z range of 800 nm).
Macrophage infection with Brucella strains
Murine J774A.1 macrophage-like cells were infected
with B. microti and B. suis strains at a multiplicity of
infection (MOI) of 20 as described previously [11]. All
experiments were performed in triplicate.
Infection of Balb/c mice with B. microti strains
Approved animal experimentation guidelines were fol-
lowed in the mouse experiments and the working pro-
tocol was approved by the CITA ethical animal
experiment committee. A procedure for the assessment
of pain, distress and discomfort in experimental ani-
mals, adapted from [31] was followed, assigning a score
to each animal regarding several variables (weight loss,
appearance, spontaneous behavior, responses to exter-
nal stimuli and clinical signs). If the score rose to 15–20
points prior to spontaneous death, animals were eutha-
nized and considered as having succumbed to infection.
Bacteria were inoculated i.p [11]. To test the lethality of
the bacterial strains, groups of six 9-weeks-old Balb/c
female mice (Janvier Labs) each were infected i.p. with
105 CFU of the wild-type, BmRΔwbkE and complemen-
ted BmRΔwbkE strains or with 108 and 109 CFU of
BmRSM and BmRΔwbkE mutant strains. Mice survival
was monitored over a period of 25 days post-infection
(d.p.i.).
To study the course of infection in mice, Balb/c were
inoculated i.p. with a dose of 104 CFU of B. microti
strains. Five mice per strain were sacrificed at 3, 14 and
21 d.p.i. Following mice euthanasia by CO2 asphyxia-
tion, spleens were aseptically collected, weighed, homo-
genized, serially diluted and plated onto TS agar for
viable counts of Brucella. The significance of differences
between strains was analyzed by the Student t-test.
P values ≤ 0.05 were considered significant.
Sequence accession number
The genomic DNA sequence of BmRSM has been depos-
ited in the SRA database (NCBI) under the accession
number PRJNA545613.
Table 1. Bacterial strains, plasmids, and primers used in this study.
Bacterial strains Acronyms Description Reference
E. coli DH5α E. coli supE44 ΔlacU169(φ80lacZΔM15)hsdR17recA1endA1 gyrA96thi-1 relA1λpir Invitrogen
B. microti CCM4915T BmSWT Wild-type reference strain, smooth phenotype [8]
B. microti RSM BmRSM Spontaneous mutant of BmSWT, rough phenotype This work
B. microti RSM
+pBBR-wbkE
BmRSMpwbkE Complemented strain of BmRSM carrying the wbkE gene in plasmid pBBR1MCS This work
B. microti ΔwbkE BmRΔwbkE Deletion mutant of BmSWT in which the wbkE gene is replaced by a kanamycin cassette This work
B. microti ΔwbkE
+pBBR-wbkE
BmRΔwbkEpwbkE Complemented strain of BmRΔwbkE carrying the wbkE gene in plasmid pBBR1MCS This work
B. suis 1330 BsSWT Wild-type reference strain, smooth phenotype ATCC
23444
B. suis ΔwbkE BsRΔwbkE Deletion mutant of BsSWT in which the wbkE gene is replaced by a kanamycin cassette This work
B. suis ΔwbkE
+pBBR-wbkE
BsRΔwbkEpwbkE Complemented strain of BsRΔwbkE carrying the wbkE gene in plasmid pBBR1MCS This work
Plasmids
pGEM®-T T/A cloning vector with ampicillin resistance marker Promega
pUC4K Plasmid vector carrying a kanamycin resistance cassette (KanR) GE
Healthcare
pBBR1MCS E. coli/Brucella shuttle vector with chloramphenicol resistance marker [29]
pGEM-T-AB pGEM-T carrying the AB PCR-fragment with sequences up- and downstream of Brucella wbkE This work
pGEMT-AB-Kan pGEM-T-AB carrying KanR in EcoRI site of the AB fragment This work
pBBR1MCS-wbkE pBBR1MCS carrying the wbkE PCR-fragment including the native gene with 398 bp up- and 600 bp
downstream regions cloned into XhoI-SacI-sites
This work
Primers Fragment Sequence (5ʹ- 3ʹ)1
Size (base
pairs)
A-BMI_I539-For A GCAGTGGATCGTGGTGTATG 526 bp
A-BMI_I539 EcoRI-Rev TGAGGTTTCATAGGCCCATCGAATTCCATGAATGGTTCGCTCAATG
B-BMI_I539-EcoRI-For B CATTGAGCGAACCATTCATGGAATTCGATGGGCCTATGAAACCTCA 595 bp
B-BMI_I539-Rev ACATTAATCGCCCGACACTC
BMI_I539-XhoI-For wbkE GCGCCTCGAGAGTTGCCATCATGAGCTTGT 1928 bp
BMI_I539-SacI-Rev GCGCGAGCTCTATCGGAAACAGTCGTGGTC
1Restriction sites are underlined, and non-homologous regions are indicated by bold type. Size of the fused AB PCR-fragment obtained using both primers
A-BMI_I539-For and B-BMI_I539-Rev, was 1075 bp. All PCRs were performed with Pfx DNA polymerase (Invitrogen) using B. microti genomic DNA as matrix.
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Results
A spontaneous rough mutant of B. microti shows
increased colonization of macrophages and is
avirulent in mice
Following the first plating of B. microti CCM4915T on TS
agar and staining with crystal violet, a rough colony was
observed. The colony was picked, subcultured three times
and stained again with crystal violet: the rough phenotype
remained stable for all colonies on plate. This strain was
named B. microti rough spontaneous mutant and abbre-
viated BmRSM.
It has been reported that rough mutant strains of
B. suis and B. melitensis exhibit reduced intracellular
survival in infected macrophages, though entry is
improved [28]. BmRSM indeed entered murine
J774A.1 macrophage cells approximately 100-fold bet-
ter than the wild-type strain and B. suis 1330, which
was used as standard reference (Figure 1). In contrast
to B. suis and B. melitensis rough strains [28], BmRSM
replicated 20-30-fold, at least up to 24 hours post-
infection (Figure 1).
To characterize the behavior of BmRSM in vivo, Balb/c
mice were injected i.p. with the sublethal dose of 104 bac-
teria, as previously published by the authors for the
B. microti wild-type strain [11]. The number of bacteria
recovered from spleen and liver 3 days after inoculation,
corresponding to the peak of infection for B. microti [11],
was reduced by 3.5 and 2.2 logs (P < 0.001), respectively,
compared to those previously obtained with the wild-type
strain (Table 2) and also confirmed in this work (see later
section on “acute murine infection”). Therefore, the rough
mutant colonized these organs significantly less than the
wild-type, resulting in the lack of a transient acute phase of
infection.
BmRSM strain is characterized by a mutation of the
glycosyltransferase-encoding gene wbkE
To identify the mutation(s) responsible for the rough
phenotype in BmRSM, its genome was sequenced and
compared with that of B. microti CCM4915T, accessible
in the NCBI database. Out of 48 variants, 28 were
assigned to SNV (Single Nucleotide Variants) and 20
to InDel (Insertion/Deletion) variants. Scrutiny of the
variants resulted in retaining of 3 SNV and 4 InDels,
fulfilling all the following criteria: (1) located within
open reading frames or in the immediate upstream
vicinity, (2) causing amino acids substitutions, frame-
shift- or stop-mutations in the corresponding genes, (3)
not located in pseudogenes, and (4) representing the
most prevalent variant according to the number of
sequencing reads (≥ 90%) with respect to the reference
sequence (Supplementary Table S1). Only four muta-
tions were intragenic and affected the following genes:
BMI_I525 (2 SNVs), BMI_I539 (1 InDel) and
BMI_I1103 (1 SNV), encoding a transposase (ISBm1),
a glycosyltransferase (wbkE) and a queuine tRNA-
ribosyltransferase (tgt), respectively. The mutation
found in wbkE was regarded as the most plausible
cause for the rough phenotype, because the homolo-
gous gene BMEI1393 of B. melitensis, located in
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Figure 1. Intracellular replication of smooth B. microti CCM4915T (triangle down), the spontaneous rough mutant of B. microti
(BmRSM; triangle up), and smooth B. suis 1330 (circle), in murine J774A.1 macrophage-like cells. The number of colony forming units
(CFU) was determined by plating serial dilutions on TS agar plates after 2 or 3 days of incubation at 37°C for B. microti and B. suis,
respectively. The experiments were performed three times in triplicate each. Data are presented as mean values ± SD of one
experiment (in triplicate).
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a highly conserved cluster of the major (wbk) genetic
region of LPS synthesis, participates in O-PS biosynth-
esis [2,27]. Protein sequences of BMI_I539 and
BMEI1393 are identical for 368 out of 369 amino
acids. In BmRSM, deletion of a T at position 452 of
wbkE causes a frameshift and the generation of
a premature stop codon at position 622. The resulting
protein sequence is therefore expected to be truncated
at position 207.
Deletion of the B. microti wbkE gene confirms its
role in smooth (S-)LPS biosynthesis and results in
enhanced macrophage uptake
To confirm that the absence of a functional wbkE is
responsible for the rough phenotype and the reduced
virulence of BmRSM, we constructed a mutant
(BmRΔwbkE) by replacing a 608-bp internal fragment
of wbkE with a KanR cassette in the parental strain.
Colony staining with crystal violet and agglutination
with anti-R antiserum [32] confirmed that BmRΔwbkE
was rough as BmRSM (Table 3). In parallel, we per-
formed a surface analysis of smooth and rough bacter-
ial strains by atomic force microscopy (AFM). AFM has
been established as a powerful imaging technique and
allows characterization of the surface morphology of
microbial cells at the nanoscale [33]. We used a force-
curve-based imaging mode where the AFM tip is
pushed toward an area of the cell surface and retracted
from it, generating a force vs. separation distance curve
encoding information about height, adhesion or elasti-
city for each image pixel. Surface topography of
B. microti wild-type and BmRΔwbkE revealed
a uniform, smooth structure for B. microti wild-type,
in contrast to a jagged, irregular structure for the
BmRΔwbkE mutant, with significantly increased rough-
ness (Figure 2(a,b); Table 3). Mapping of the adhesion
forces between the tip and the bacterial surface also
revealed the presence of large patches of increased
adhesion at the surface of BmRΔwbkE when compared
with the surface of wild-type bacteria, suggesting
important differences in the molecular structure of the
BmRΔwbkE mutant surface (Figure 2(a,c); Table 3).
Both rough mutants BmRΔwbkE and BmRSM were
then complemented with an intact copy of wbkE cloned
in vector pBBR1MCS, which restored the smooth phe-
notype, as evidenced by lack of crystal violet staining
and by the agglutination with anti-M antiserum only
[8] (Table 3). In addition, AFM confirmed a smooth
surface structure of complemented BmRΔwbkE, with
roughness and adhesion forces back to wild-type levels
(Figure 2, Table 3).
The BmRΔwbkE mutant entered J774A.1 cells to an
extent similar to that of the BmRSM mutant (100 times
more efficient than the parental strain) and replicated 60-
fold over 30 hours (Figure 3(a)). In contrast, BmRΔwbkE
and BmRSM strains complemented with an intact copy of
wbkE infected macrophages like the parental strain and
Table 2. Balb/c mice liver and spleen colonization by B. microti
S and RSM strains 3 days post-inoculation.
Strains
Bacteria/spleen (log10
CFU)
Bacteria/liver (log10
CFU)
B. microti CCM4915T
Smooth
6.52 ± 0.16a 5.43 ± 0.21a
B. microti RSM 3.09 ± 0.59 3.27 ± 0.31
Results represent means ± SD. Differences between both strains are sig-
nificant in both organs (P < 0.001).
a Previously published data [11]
Table 3. Phenotypes of S and R strains of B. microti and B. suis.
Atomic Force Microscopy
Strains Crystal violet staininga Serum agglutinationb Roughness, nm ± SD Adhesion, pN ± SD
B. microti CCM4915T
Smooth
- M 2.2 ± 0.67
124.6 ± 26
B. microti RSM + R NDc ND
B. microti RSM +
pBBR-wbkE
- M ND ND
B. microti ΔwbkE + R 7.8 ± 4.35 446 ± 120.4
B. microti
ΔwbkE + pBBR-
wbkE
- M 2.6 ± 1.57 166.1 ± 34.9
B. suis 1330
Smooth
- A ND ND
B. suis 1330
ΔwbkE
+ R ND ND
B. suis 1330
ΔwbkE + pBBR-
wbkE
- A ND ND
a +, uptake; -, no uptake of crystal violet by the colonies
b with monospecific A, M, or R polyclonal antisera
c not determined
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replicated 400- and 250-fold, respectively (Figure 3(a)).
An isogenic wbkE mutant of B. suis 1330 (BsRΔwbkE) was
also constructed in order to compare its behavior to that
of other rough mutants described in the past [25,28]. As
expected, the BsRΔwbkE mutant retained crystal violet and
agglutinated with anti-R antiserum (Table 3). It colo-
nized the macrophages 12 times more efficiently than
the wild-type, but in contrast to R-strains of B. microti,
a 3-fold reduction in intracellular survival was observed
within a period of 30 h, resulting in 100 times lower
Figure 2. Atomic Force Microscopy (AFM) images of B. microti wild-type (Bm WT), ΔwbkE mutant (Bm RΔwbkE) and the comple-
mented ΔwbkE mutant (Bm RΔwbkE compl). (a) Each column shows from top to bottom the vertical deflection image (height) of the
whole bacteria and 0.3 × 0.3 µm2 areas of the cell surface, representing roughness and adhesion recorded on the shown bacteria
(blue square). Quantitative roughness (b) and adhesion (c) measurements of Bm WT, Bm RΔwbkE and complemented Bm RΔwbkE:
0.5 × 0.5 µm2 images were recorded and used for measurements of 0.25 × 0.25 µm2 areas to quantify arithmetic roughness Ra and
adhesion (Peak-to-Valley). n = 9 bacteria/strain. Statistical differences were analyzed by t-test and yielded P values < 0.001 when
comparing Bm WT or Bm RΔwbkE compl with Bm RΔwbkE. Image analysis was done with Gwyddion [34].
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viable counts when compared to the wild-type
(Figure 3(b)). This was very similar to the behavior of the
manBcore mutant of B. suis 1330 [25]. The complemented
BsRΔwbkE strain agglutinated specifically with anti-A anti-
serum as the wild-type strain (Table 3) and showed wild-
type levels of intracellular infection and replication,
despite a stronger transitional decrease in the early
phase of infection (Figure 3(b)).
The B. microti wbkE gene is indispensable for acute
murine infection
Infection of Balb/c with 104 CFU of B. microti strains
showed a 3-logs reduction of BmRΔwbkE in the spleen at
day 3 post-injection, as compared to the wbkE-comple-
mented mutant and wild-type strains (Figure 4(a)), con-
firming the incapacity of a ΔwbkE mutant strain to
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Figure 3. Intracellular replication of smooth and rough strains of B. microti (a) and B. suis (b) in murine J774A.1 macrophage-like
cells. (a) B. microti CCM4915T wild-type (filled triangle down), the spontaneous R-strain BmRSM (open triangle up), the complemented
BmRSM mutant (filled triangle up), the constructed R-strain BmRΔwbkE (open circle), and the complemented BmRΔwbkE mutant (filled
circle). (b) B. suis 1330 wild-type (filled triangle down), the constructed R-strain BsRΔwbkE (open circle), and the complemented BsRΔwbkE
mutant (filled circle). The complemented strains expressed native wbkE cloned into the replicative plasmid pBBR1MCS. The
experiments were performed three times in triplicate each. Data are presented as mean values ± SD of one experiment (in triplicate).
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Figure 4. Infection of Balb/c mice with B. microti strains: growth and survival of B. microti strains in the spleen (a) and spleen weights
of infected animals (b) after i.p. inoculation of 104 bacteria. The number of viable B. microti CCM4915T wild-type (black bars),
BmRΔwbkE strain (open bars), and complemented BmRΔwbkE mutant (grey bars) was determined at days 3, 14, and 21 post-infection.
The arrow indicates the infection dose of 104 bacteria. Five mice were sacrificed per bacterial strain and time point, and values
represent means ± SD. Asterisks indicate variable significance of the differences between the R-strain and the wild-type (next to left
bar) or R-strain and the complemented mutant (next to right bar), or between the R-strain and both the wild-type and the
complemented mutant (above middle bar): * P < 0.05; ** P < 0.005; *** P < 0.001.
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establish an acute phase of infection in the host (see also
Table 2). The acute infection phase observed with the wild-
type and the wbkE-complemented strains was followed by
an increase of the spleen weight until at least day 14,
reflecting an inflammatory response (Figure 4(b)). In con-
trast, mice infected with BmRΔwbkE did not gain spleen
weight. A similar finding was obtained when the strain
BmRSM was injected i.p. at 104 CFU, as spleen weights
remained unchanged at day 3 and day 14 (0.09 ± 0.007
and 0.10 ± 0.015, respectively; P < 0.001), confirming
a reduced immune response induction with the wbkE-
mutant rough strains.
The wbkE gene is essential for the lethal character
of B. microti infections in Balb/c mice
Our previous work showed that the intra-peritoneal injec-
tion of 105 CFU of B. microti CCM4915T caused the death
of 83% of the Balb/cmice within four days of infection [11].
To investigate the possible involvement of thewbkE gene in
the lethal outcome of a B. microti infection, the suscept-
ibility of Balb/c mice infected with BmRSM or BmRΔwbkE
was compared to that observed following infection with the
B. microti CCM4915T wild-type and the complemented
BmRΔwbkE strains, over a monitoring period of 25 days
(Table 4): 67% and 83% of the mice infected with the
standard dose of 105 CFU of the wild-type or the comple-
mented BmRΔwbkE strain, respectively, died between days 2
and 6 post-inoculation. In striking contrast, all the mice
infected with 105 CFU of BmRΔwbkE survived without any
symptoms. 100% survival was also observed for both
R-mutant strains BmRSM and BmRΔwbkE after the injection
of 108 CFU. However, when inoculated with 109 CFU of
either R-strain, all mice died between days 2 and 6 post-
inoculation. These results are even more notable if com-
bined with our preliminary observation (not shown) that
BmRSM in Balb/c mice provided protection against
B. microti wild-type, B. abortus, B. melitensis and B. suis
1330.
Discussion
The non-canonical LPS of classical brucellae lacks endotoxicity
and possesses a particular core structure helping to evade the
host’s immune system [35,36]. The phenomenon of dissocia-
tion, resulting in the conversionof S- toR-phenotype, has been
first described for Brucella in 1933 [37]. More recently,
B. abortus, B. melitensis and B. suis R-mutants devoid of
O-PS have been studied in cellular and murine models of
infection [25,27,28,38,39]. These studies consistently showed
the relevance of O-PS for virulence. The reduced virulence of
R-mutants has been attributed to (1) high sensitivity to com-
plement-mediated lysis in mice [40,41], (2) lipid raft-
independent entry into macrophages resulting in enhanced
phagolysosome fusion [25], and (3) lackof intracellular replica-
tiondue tomacrophageactivation[28].Monoclonal antibodies
specific for common O-PS epitopes of A- or M-dominant
classical strains also recognize LPS of the M-dominant
B.microti reference strain [14], indicatingaconservedstructure
of O-PS. However, anti-R-LPS monoclonal antibodies do not
react with B. microti LPS, suggesting structural specificities in
the core-lipid A moiety of its LPS [14], which may result in
enhanced endotoxic properties and possibly explain the killing
ability of B. microti in the murine model of infection.
Because of the lack of data available on atypical species
mutants affected in O-PS biosynthesis, we investigated the
virulence properties of a spontaneous R-mutant of
B. microti, which was fortuitously isolated. Murine infec-
tion experiments showed a loss of lethality of this mutant,
and subsequent analysis by whole-genome sequencing
allowed to link this ability to the wbkE gene, encoding
a glycosyltransferase located in themajorO-PSbiosynthesis
region, as previously described for B. melitensis [27].
Complementation of R-mutants restoredwild-type proper-
ties including smooth character, reducedmacrophage entry
and murine lethality, demonstrating that the BmRSM strain
was affected in a single LPS biosynthesis gene. In contrast,
spontaneous R-mutants of B. abortus and B. melitensis iso-
lated from macrophage and murine infections were often
simultaneously affected in several loci [42]. Cell surface
structure analysis by AFM confirmed the smooth character
of the wild-type and complemented BmRΔwbkE strains,
whereas a distinct irregular surface was recorded for
BmRΔwbkE, possibly due to exposure of outer membrane
proteins and lipidA/outer core disaccharides in the absence
of the O-chain [27]. This exposure may also explain the
increased adhesion forces observed during the interaction
of the AFM tip with the R-mutant surface. Conversely, in
a recent report, AFM analysis of two B. abortus strains,
a wild-type and its isogenic mutant Δgmd R lacking
O-chain, shows similar degrees of roughness [43].
Structural differences in the LPS core-lipid A moieties of
Table 4. Lethality of B. microti S and R strains in Balb/c mice
Strains Infection dose (i.p.) % Mortalityab
B. microti CCM4915T Smooth 105 67
B. microti RSM 108 0
109 100
B. microti ΔwbkE 105 0
108 0
109 100
B. microti ΔwbkE+ pBBR-wbkE 105 83
a Each bacterial strain was inoculated to a group of six 9-weeks-old Balb/c
female mice
b Over a 25-days period of monitoring, murine death occurred between days
2 and 6 post-inoculation
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B. microti and B. abortus could be a reason for this
divergence.
In the macrophage model of infection, BmRΔwbkE and
BmRSM replicated to a number of intracellular bacteria higher
than that observed for the wild-type, in part due to the
increased rate of entry (100 times). The latter was also
described previously for R-mutants of classical species, but
with variations in intracellular survival, reaching at best the
initial level post-phagocytosis [25,28,44]. Interestingly, this
was also confirmed for BsRΔwbkE, leading to the hypothesis
that B. suis and B. microti R-mutants may use distinct intra-
cellular trafficking pathways depending on sites of entry and
resulting in specific phagolysosome fusion and escape
kinetics. Measurement of NO- and TNF-α-production by
infectedmacrophagesyieldedonlyminordifferencesbetween
BsRΔwbkE and BmRΔwbkE strains, indicating that these
immune mediators were not involved (not shown).
Intramacrophagic replication and high intracellular loads
of bacteria are essential for the lethal phenotype of B. microti
in vivo, with themajor virulence factor VirB playing a crucial
role [12]. We assume that massive intracellular replication of
the pathogen and increased cell lysis results in high concen-
trations of circulating bacteria, infecting new cells and leading
to septic shock andmurine death, possibly due to a modified
core-lipid A moiety. However, intramacrophagic replication
is not sufficient, as shown for the R-mutant. Lack of murine
lethality after infection with R-mutants may indeed be
explained by increased sensitivity to complement-mediated
lysis, keeping the overall concentrations of bacteria too low to
trigger an endotoxic shock and, at a sublethal dose, strongly
reducing the load of infected macrophages prior to their
settling in the spleen and mitigating the inflammatory reac-
tion. The biological potential of dissociation based on
enhanced dissemination of S-bacteria in the presence of
R-forms inducing cytotoxicity has been discussed in the con-
text of B. abortus and B. melitensis infections [42,45], but in
the case of rough B. microti, final bacterial loads in the
macrophage are even higher thanwith the wild-type, making
a cytotoxic effect unlikely. Given the different natural habitats
of B. microti and the observation that B. microti strains
isolated from soil were rough [32], we speculate that the
R-phenotype either confers an advantage to this species out-
side the host or appears at higher rates due to the absence of
selective pressure to which intracellular smooth organism
may be exposed.
In surveillance and control of livestock brucellosis, the
distinction between infected and vaccinated animals
remains a major challenge, since field strains and the
commonly used efficient vaccine strains, B. abortus S19
and B. melitensis Rev1, both possess a S-LPS, which is the
relevant diagnostic antigen recognized by anti-Brucella
antibodies following infection or vaccination. Therefore,
O-PS mutants are interesting vaccine candidates, as they
do not elicit an antibody response undistinguishable from
that induced during active infection. As a matter of fact,
B. abortus RB51 has been commercialized as a rough vac-
cine strain, despite its controversial effectiveness and draw-
backs [46]. Based on our preliminary data in mice, we
suggest that the spontaneous, well-characterized R-strain
of B. microti described in this study, or a R-mutant deletion
strain devoid of the antibiotic resistance marker, might
thus be exploited as a potential DIVA (Differentiating
Infected from Vaccinated Animals)-vaccine candidate
against animal brucellosis, with the potential advantage to
confer a broad-range protection against heterologous
Brucella species pathogenic for livestock.
In summary, we have described R-mutants of the atypi-
cal species B. microti defective in wkbE expression/activity
in cellular and in vivo models of infection. Together with
VirB, the S-LPSwas identified as a virulence factor essential
for lethality of B. microti in the murine model of infection.
Further characterization of its LPS structure, elucidation of
intracellular trafficking, and additional in vivo studies in
livestock animals will showwhether B.microtiR-strains are
suitable live vaccines against brucellosis.
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